dimethyl itaconate has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghia, P; Mantione, ME; Meloni, M; Muzio, M; Ranghetti, P; Riba, M; Sana, I; Scarfò, L | 1 |
1 other study(ies) available for dimethyl itaconate and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
Dimethyl itaconate selectively targets inflammatory and metabolic pathways in chronic lymphocytic leukemia.
Topics: Animals; Leukemia, Lymphocytic, Chronic, B-Cell; Metabolic Networks and Pathways; Mice; Signal Transduction; Toll-Like Receptors; Tumor Microenvironment | 2023 |